---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000095"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T02:09:02.670864+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q2 revenue $73.2M beats midpoint; raises FY2023 guidance

## Summary
- Total revenue $73.2M (+4% YoY) vs guidance midpoint of $72.3M.
- Adjusted EBITDA $3.5M vs guidance midpoint of $2.75M; margin ~5% (+200 bps YoY).
- Two large TEMS contracts signed: ~$50M and ~$60M, each with existing health system clients.
- FY2023 revenue guidance raised to $290.5M–$295.5M; Adjusted EBITDA raised to $10.0M–$12.0M.
- Net loss improved to $32.6M from $33.4M YoY; dollar-based retention reiterated at 102%–110%.

## SEC filing metadata
- accession: 0001636422-23-000095
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000095/0001636422-23-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000095/hcat-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000095
- JSON: https://secwatch.observer/filing/0001636422-23-000095.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000095.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported the quarter ended June 30, 2023 results: revenue $73.2 million. Guidance raised.
  - Period: the quarter ended June 30, 2023
  - Revenue: $73.2 million
  - Guidance: raised
  - Result: reported results
  source text: today reported financial results for the quarter ended June 30, 2023. “For the second quarter of 2023, we are encouraged by our financial results, including total revenue of $73.2 million and Adjusted EBITDA of $3.5 million, with these results beating the mid-point of our quarterly guidance on each metric. Additionally, given that we are tracking slightly ahead of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000095/0001636422-23-000095-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.